Easton Pharmaceuticals, Inc. (EAPH)

[mjk_investor]

I've been pondering the same question myself, here's what I come up with.

1. fatigue among long time shareholders
2. company's inability to attract new investors
3. based on past deeds, people hold EAPH to higher standard than other OTC stocks. They want to see audited financial statements, sec filings, etc. Things 90% of other OTC penny stocks don't do, but get a pass.
4. the posters calling for .15 for the iBliss deal and .30 cents for a bayer deal are way off the mark, clearly!

My observations for what's it's worth.

GLTA